Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Pikija, S; Peycheva, MV; Aghayan-Ugurluoglu, R; Ganser, B; Trinka, E.
Central retinal artery occlusion in a patient with sickle cell disease treated with recombinant tissue plasminogen activator.
Folia Med (Plovdiv). 2022; 64(5): 840-843.
Doi: 10.3897/folmed.64.e67881
(- Case Report)
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Pikija Slaven
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Central retinal artery occlusion is a rare ophthalmological complication of sickle cell disease, usually provoked by additional contributing risk factors and its treatment remains controversial. We describe a patient with sickle cell disease and a spontaneous central retinal artery occlusion of his left eye that probably has good result from intravenous thrombolysis. We want to add sickle cell disease as rare etiological cause of central retinal artery occlusion and perpetuate evidence of intravenous recombinant tissue plasminogen activator administration in this condition.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Tissue Plasminogen Activator - administration & dosage
- Retinal Artery Occlusion - administration & dosage
- Anemia, Sickle Cell - administration & dosage
- Patients - administration & dosage
- Risk Factors - administration & dosage